Jane Street’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.44M Sell
17,167
-649,544
-97% -$353M ﹤0.01% 2754
2025
Q4
$386M Buy
666,711
+506,958
+317% +$287M 0.06% 221
2025
Q3
$77.5M Sell
159,753
-182,722
-53% -$85.1M 0.01% 710
2025
Q2
$139M Buy
342,475
+281,390
+461% +$118M 0.03% 366
2025
Q1
$30.4M Sell
61,085
-365,215
-86% -$198M 0.01% 982
2024
Q4
$222M Buy
426,300
+420,025
+6,694% +$231M 0.05% 222
2024
Q3
$3.88M Sell
6,275
-304,351
-98% -$180M ﹤0.01% 3272
2024
Q2
$172M Buy
310,626
+219,193
+240% +$126M 0.04% 243
2024
Q1
$53.1M Buy
91,433
+9,684
+12% +$5.43M 0.01% 600
2023
Q4
$43.4M Sell
81,749
-76,812
-48% -$37.2M 0.01% 758
2023
Q3
$80.3M Buy
158,561
+33,336
+27% +$17.8M 0.03% 394
2023
Q2
$65.3M Buy
125,225
+80,567
+180% +$43.5M 0.02% 485
2023
Q1
$25.7M Sell
44,658
-6,318
-12% -$3.56M 0.01% 841
2022
Q4
$28.1M Sell
50,976
-62,675
-55% -$33.2M 0.01% 796
2022
Q3
$57.6M Buy
113,651
+42,691
+60% +$23.9M 0.03% 462
2022
Q2
$38.6M Buy
70,960
+8,426
+13% +$4.64M 0.02% 678
2022
Q1
$36.9M Buy
62,534
+25,382
+68% +$14.6M 0.01% 848
2021
Q4
$24.8M Sell
37,152
-8,412
-18% -$5.25M 0.01% 1031
2021
Q3
$26M Sell
45,564
-80,619
-64% -$44.2M 0.01% 953
2021
Q2
$63.7M Sell
126,183
-13,337
-10% -$6.29M 0.02% 452
2021
Q1
$63.7M Buy
139,520
+94,972
+213% +$45.3M 0.03% 411
2020
Q4
$20.8M Buy
44,548
+35,838
+411% +$16.8M 0.01% 846
2020
Q3
$3.85M Sell
8,710
-64,470
-88% -$26.6M ﹤0.01% 2148
2020
Q2
$26.5M Buy
73,180
+40,051
+121% +$13.4M 0.02% 616
2020
Q1
$9.39M Buy
+33,129
New +$10.4M 0.01% 808
2019
Q4
Sell
-13,543
Closed -$4.11M 5753
2019
Q3
$3.94M Buy
13,543
+9,871
+269% +$2.83M 0.01% 1168
2019
Q2
$1.08M Sell
3,672
-31,519
-90% -$8.68M ﹤0.01% 2604
2019
Q1
$9.63M Buy
35,191
+14,452
+70% +$3.6M 0.02% 712
2018
Q4
$4.64M Buy
20,739
+19,365
+1,409% +$4.54M 0.01% 998
2018
Q3
$335K Sell
1,374
-17,450
-93% -$4.01M ﹤0.01% 4076
2018
Q2
$3.9M Buy
18,824
+12,713
+208% +$2.7M 0.01% 1267
2018
Q1
$1.26M Buy
6,111
+854
+16% +$179K ﹤0.01% 2363
2017
Q4
$998K Sell
5,257
-22,239
-81% -$4.26M ﹤0.01% 2348
2017
Q3
$5.2M Buy
27,496
+22,980
+509% +$4.16M 0.02% 846
2017
Q2
$788K Sell
4,516
-5,469
-55% -$919K ﹤0.01% 2480
2017
Q1
$1.53M Buy
9,985
+3,528
+55% +$539K 0.01% 1616
2016
Q4
$911K Sell
6,457
-6,418
-50% -$946K ﹤0.01% 2189
2016
Q3
$2.05M Buy
+12,875
New +$1.98M 0.01% 1184
2016
Q1
Sell
-21,633
Closed -$2.9M 4636
2015
Q4
$3.07M Buy
21,633
+13,854
+178% +$1.85M 0.02% 758
2015
Q3
$951K Buy
7,779
+5,758
+285% +$750K 0.01% 1677
2015
Q2
$262K Buy
+2,021
New +$263K ﹤0.01% 2967
2014
Q4
Sell
-12,774
Closed -$1.55M 3031
2014
Q3
$1.55M Buy
+12,774
New +$1.55M 0.02% 701
2014
Q2
Sell
-11,753
Closed -$1.41M 3116
2014
Q1
$1.41M Buy
+11,753
New +$1.4M 0.02% 733
2013
Q4
Sell
-26,861
Closed -$2.48M 2889
2013
Q3
$2.48M Buy
26,861
+11,461
+74% +$1.04M 0.03% 474
2013
Q2
$1.3M Buy
+15,400
New +$1.28M 0.02% 698

Other funds holding TMO

Jane Street's TMO Position: Q1 2026 in Review

Jane Street reduced its Thermo Fisher Scientific (TMO) stake by 97% in Q1 2026, selling an estimated $353M and leaving 17,167 shares worth $8.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2754.

Jane Street first reported a position in TMO in Q2 2013 and has held it in 45 quarters since. The position peaked at $386M in Q4 2025. 2,598 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Jane Street held 17,167 shares of Thermo Fisher Scientific worth $8.44M as of Q1 2026.
  • Jane Street sold 649,544 Thermo Fisher Scientific shares in Q1 2026, an estimated $353M.
  • Thermo Fisher Scientific made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #2754 holding.
  • Jane Street first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 45 quarters since.
  • Jane Street's Thermo Fisher Scientific position peaked at $386M in Q4 2025.
  • 2,598 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.